PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23301526-0 2014 Tacrolimus abrogates TGF-beta1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. Tacrolimus 0-10 transforming growth factor beta 1 Homo sapiens 21-30 23301526-4 2014 Tacrolimus (FK506) ointment has been reported to be effective for treating AD as well as some TGF-beta1-induced fibrotic diseases. Tacrolimus 0-10 transforming growth factor beta 1 Homo sapiens 94-103 23301526-4 2014 Tacrolimus (FK506) ointment has been reported to be effective for treating AD as well as some TGF-beta1-induced fibrotic diseases. Tacrolimus 12-17 transforming growth factor beta 1 Homo sapiens 94-103 23301526-5 2014 OBJECTIVES: To evaluate the effect of tacrolimus on TGF-beta1-stimulated cultured normal human dermal fibroblasts and explore the potential signalling pathways involved. Tacrolimus 38-48 transforming growth factor beta 1 Homo sapiens 52-61 23301526-9 2014 RESULTS: Our results revealed that the increased expressions of transforming growth factor-beta receptor I (TGF-betaRI) and TGF-betaRII in TGF-beta1-treated fibroblasts were suppressed by tacrolimus treatment. Tacrolimus 188-198 transforming growth factor beta 1 Homo sapiens 139-148 23301526-10 2014 In addition, tacrolimus significantly inhibited fibroblast proliferation enhanced by TGF-beta1. Tacrolimus 13-23 transforming growth factor beta 1 Homo sapiens 85-94 23301526-11 2014 TGF-beta1 increased type I collagen production, and this enhancing effect was suppressed by tacrolimus. Tacrolimus 92-102 transforming growth factor beta 1 Homo sapiens 0-9 23301526-12 2014 The down-regulation of MMP-1 and up-regulation of TIMP-1 induced by TGF-beta1 were reversed by tacrolimus. Tacrolimus 95-105 transforming growth factor beta 1 Homo sapiens 68-77 23301526-13 2014 The increase in phosphorylated p38 mitogen-activated protein kinase (p38MAPK) expression stimulated by TGF-beta1 was down-regulated by tacrolimus. Tacrolimus 135-145 transforming growth factor beta 1 Homo sapiens 103-112 23301526-15 2014 CONCLUSIONS: The present results demonstrated that tacrolimus significantly inhibited physiological functions of fibroblasts enhanced by TGF-beta1 in vitro. Tacrolimus 51-61 transforming growth factor beta 1 Homo sapiens 137-146